Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
Appointed director

PhaseBio Pharmaceuticals Inc (PHAS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 8-K Resignation/termination of a director
09/27/2023 8-K Quarterly results
08/25/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE",
"UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE"
06/30/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Case 22-10995-LSS Doc 665 Filed 06/22/23 Page 1 of 12 Case 22-10995-LSS Doc 665 Filed 06/22/23 Page 2 of 12 Aggregate Total Itemized Breakdown by Firm Case 22-10995-LSS Doc 665 Filed 06/22/23 Page 3 of 12"
05/10/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE"
03/24/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE"
02/24/2023 8-K Other Events  Interactive Data
Docs: "Case 22-10995-LSS Doc 508 Filed 02/21/23 Page 1 of 12 Case 22-10995-LSS Doc 508 Filed 02/21/23 Page 2 of 12 Aggregate Total Itemized Breakdown by Firm Case 22-10995-LSS Doc 508 Filed 02/21/23 Page 3 of 12"
01/25/2023 8-K Termination of a Material Definitive Agreement, Other Events  Interactive Data
Docs: "UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE"
01/17/2023 8-K Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Completion of Acquisition or Disposition of Assets, F...
Docs: "SETTLEMENT AGREEMENT This Settlement Agreement",
"PROGRAM TRANSFER AGREEMENT THIS PROGRAM TRANSFER AGREEMENT"
12/23/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
Docs: "Case 22-10995-LSS Doc 294 Filed 12/21/22 Page 1 of 12 Case 22-10995-LSS Doc 294 Filed 12/21/22 Page 2 of 12 Aggregate Total Itemized Breakdown by Firm Case 22-10995-LSS Doc 294 Filed 12/21/22 Page 3 of 12"
12/02/2022 8-K Quarterly results
11/23/2022 8-K Quarterly results
11/08/2022 8-K Quarterly results
10/31/2022 8-K Quarterly results
10/24/2022 8-K Quarterly results
10/07/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
09/27/2022 8-K Other Events  Interactive Data
08/12/2022 8-K Quarterly results
Docs: "PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights",
"Corporate Overview August 2022"
08/08/2022 8-K Quarterly results
07/05/2022 8-K Quarterly results
05/20/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
04/04/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
03/24/2022 8-K Quarterly results
Docs: "PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights",
"Corporate Overview March 24, 2022"
12/21/2021 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
11/15/2021 8-K Investor presentation
Docs: "PROPRIETARY LONG-ACTING INJECTABLE RECOMBINANT BIOPOLYMERS"
11/10/2021 8-K Quarterly results
Docs: "Corporate Overview November 2021"
11/03/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
09/15/2021 8-K Quarterly results
08/12/2021 8-K Quarterly results
Docs: "PhaseBio Reports Second-Quarter 2021 Financial Results and Recent Business Highlights",
"Corporate Presentation",
"PhaseBio Pharmaceuticals Achieves Enrollment Milestones Supporting Interim Analysis of REVERSE-IT Global Phase 3 Trial, Enabling Preparation of a BLA submission for Bentracimab for Reversal of Antiplatelet Effects of Ticagrelor First 143 patients enrolled in the pivotal Phase 3 trial, with top-line results from interim analysis expected later this year"
08/10/2021 8-K Quarterly results
06/17/2021 8-K Quarterly results
06/04/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy